Patients treated with intravitreal triamcinolone acetonide [from Gallenga and Lobefalo] and Response to correspondence [from Kocabora]  ||FREE PAPER||
Pier E Gallenga1, Lucio Lobefalo21University Eye Clinic, G.D’Annunzio University, Chieti, Italy; 2Ethical Committee, Italian Ophthalmological Society – SOI, ItalyThe paper by Kocabora and coworkers (2008) underlines the message that patients treated with intravitreal tria...
Guardado en:
Autores principales: | Pier E Gallenga, Lucio Lobefalo, M Selim Kocabora |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd005902712d4e0daab2add1786f68cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
por: Ume Sughra, et al.
Publicado: (2021) -
Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone
por: M Selim Kocabora, et al.
Publicado: (2008) -
Diabetic macular edema: Safe and effective treatment with intravitreal triamcinolone acetonide (Taioftal).
por: Francesco Saverio Sorrentino, et al.
Publicado: (2021) -
Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors
por: Ziad F Bashshur, et al.
Publicado: (2008) -
Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
por: Marey HM, et al.
Publicado: (2011)